Abstract
Studies of myeloid leukemic cell lines and primary cultures of leukemic bone marrow have yielded information on humoral regulation of growth and differentiation of myeloid cells and have revealed specific abnormalities in regulatory control that would appear to play important roles in the development and progression of hematopoietic neoplasia. Already considerable in vitro data have been accumulated to document the feasibility of the clinical application of such biological response modifiers as Retinoic acid, interferon, tumor necrosis factor, prostaglandin E, and differentiation-inducing proteins in a strategy designed to revert malignant hematopoietic cells to a pattern of normal proliferation and differentiation, or to mediate their selective ablation. Evidence that an effective cancer therapy can be based on induction of a phenotypic reversion of the tumor cell as well as by direct killing of tumor cells has been based on extensive studies on leukemic cell lines such as Friend mouse erythroleukemic cells (39), mouse myeloid (Ml) and myelomonocytic (WEHI- 3) cell lines (33, 71), and human HL-60 myeloid leukemic cells (40). These cell lines can be induced to differentiate and lose self-renewal and leukemogenic capacity following exposure to a variety of chemical agents, including some anticancer drugs (52, 109).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abe, E.; Miyaura, C.; Sakagami, H.; Takeda, M.; Konno, K.; Yamazaki, T.; Yoshiki, S.; and Suda, T. 1981. Proc. Natl. Acad. Sci. USA 78(8): 4990–4994.
Akagawa, K.S., and Tokunaga, T. 1980. Microbiol. Immunol. 24(10): 1005–1101.
Allen, T.D. 1978. In Lord, The Second Symposium of the British Society for Cell Biology on Stem Cells and Tissue Homeostasis, eds. C. Potten and D. Cole, pp. 217–240. Cambridge, England: Cambridge University Press.
Anderson, L.C.; Nilsson, K.; and Gahmberg, C.G. 1979. Intl. J. Cancer 23: 143.
Arce, J.M.; Naughton, B.A.; Kolks, G.A.; et al. 1981. Prostaglandin 21: 367–377.
Bernstein, S.E. 1970. Am. J. Surgery 119: 448–451.
Bodel, P. 1978. J. Exp. Med. 147: 1503.
Breitman, T.R.; Selonick, S.E.; Keene, B.R.; Richardson, E.; and Collins, S.J. 1980. Proc. Natl. Acad. Sci. USA 77: 2936–2940.
Broxmeyer, H.E.; Grossbard, E.; Jacobsen, N.; and Moore, M.A.S. 1979. N. Engl. J. Med. 301: 346–351.
Broxmeyer, H., and Ralph, P. 1977. Cancer Res. 37: 3578.
Buick, R.N.; Till, J.E.; and McCulloch, E.A. 1977. Lancet 1: 862.
Burgess, A.W., and Metcalf, D. 1980. Blood 56: 947.
Castro-Malaspina, H.; Ebell, W.; and Wang, S.Y. 1984. Human Bone Marrow Fibroblast Colony-Forming Units (CFU-F). In Myelofibrosis and the Biology of Connective Tissue, eds. P. Berk and H. Castro-Malaspina, pp. 209–236. New York: Alan Liss, Inc.
Castro-Malaspina, H.; Gay, R.E.; Jhanwar, S.C.; Hamilton, J.A.; Chiarieri, D.R.; Meyers, P.A.; Gay, S.; and Moore, M.A.S. 1982. Blood 59: 1046–1054.
Castro-Malaspina, H.; Gay, R.E.; Resnick, G.; Kapoor, N.; Meyers, P.; Chiarieri, D.; McKenzie, S.; Broxmeyer, H.E., and Moore, M.A.S. 1980. Blood 59: 289–301.
Collins, S.J.; Gallo, R.C.; and Gallagher, R.E. 1977. Nature 207: 347.
Collins, S.J.; Ruscetti, F.W.; Gallagher, R.E.; and Gallo, R.C. 1979. J. Exp. Med. 149: 969.
Creusot, F.; Schneiderman, N.; Herzog, D.; Acs, G.; and Christman, J.K. 1982. Biol. Cell 45(2): 96.
Delmonte, L.; O’Reilly, R.J.; and Kirkpatrick, D. 1982. Transplantation 34: 100–103.
Dexter, T.M.; Allen, T.D.; and Lajtha, L.G. 1977. J. Cell Physiol. 91: 335–344.
Dexter, T.M., and Moore, M.A.S. 1977. Nature 269: 412–414.
Dexter, T.M., and Testa, M.G. 1976. Methods in Cell Biology, ed. D.M. Prescott, vol. 14, pp. 387–405. New York: Academic Press.
Dinsmore, R.E.; Strauss, D.J.; Pollock, M.S.; Garret, T.J.; Young, C.W.; Clarkson, B.D.; and Dupont, B. 1980. Blood 55: 831–834.
Douer, D., and Koeffler, H.P. 1982. J. Clin. Invest. 69(2): 277–283.
Douer, D., and Koeffler, H.P. 1982. Exp. Cell Res. 138: 193–197.
Egorin, M.; Fox, B.; Spiegel, J.; Gutierrez, P.; Friedman, R.; and Bachur, N. 1982. Am. Ass. Cancer Res. Abstract 696.
Elias, L.; Wogenrich, F.J.; Wallace, J.M.; and Longmire, J. 1980. Leuk. Res. 4(3): 301–303, 305–307.
Falk, A., and Sachs, L. 1980. It. J. Cancer 26: 595–601.
Fauser, A.A.; Kanz, L.; and Katz, R. 1982. Blood 60(Suppl.1): 144a.
Fauser, A.A., and Messner, H.A. 1978. Blood 52: 1243.
Fauser, A.A., and Messner, H.A. 1979. Blood 53: 1023.
Fauser, A.A.; Neumann, H.A.; Bross, K.G.; et al. 1982. Blood 60: 1317.
Fibach, E.; Hayashi, M.; and Sachs, L. 1973. Proc. Natl. Acad. Sci. USA 70: 343–346.
Fogh, J. 1977. Natl. Cancer Inst. 58: 209–214.
Fogh, J.; Trempe, L.; and Fogh, H., eds. 1975. New York: Plenum Press.
Folkman, J., and Haudenschild, C.C. 1982. In Pathobiology of the Endothelial Cell, eds. H.L. Nossel and H.J. Vogel, pp. 79–93. New York: Academic Press.
Folkman, J.; Haudenschild, C.C.; and Zetter, B.R. 1979. Proc. Natl. Acad. Sci USA 76: 5217–5221.
Friedenstein, A.J.; Ivanov-Smolenski, A.A.; Chajlakjan, R.K.; Gorskaya, U.F.; Kuralesova, A.I.; Latzinik, N.W.; and Gerasimow, U.W. 1978. Exp. Hematol. 6: 440–444.
Friend, C.; Scher, W.; Holland, J.G.; and Sato, T. 1971. Proc. Natl. Acad. Sci. USA 68: 378–383.
Gallagher, R.; Collins, S.; Trujillo, J.; McCreedie, K.; Ahern, M.; Tsai, S.; Metzgar, R.; Aulakh, G.; Ting, R.; Ruscetti, F.; and Gallor, R. 1979. Blood 54: 713–720.
Gallo, R.C.; Breitman, T.R.; and Ruscetti, F.W. 1982. In Maturation Factors in Cancer, ed. M.A.S. Moore, pp. 255–271. New York: Raven Press.
Gartner, S., and Kaplan, H.S. 1980. Proc. Natl. Acad. Sci. USA 77: 4756–4759.
Gatti, R.A.; Meuwissen, H.J.; Allen, H.D.; Hong, R.; and Good, R.A. 1968. Lancet 2: 1366–1369.
Golde, D.W.; Hocking, W.G.; Quan, S.G.; Sparkes, R.S.; and Gale, R.P. 1980. Brit. J. Haemat. 44: 183–187.
Goldman, R.; Faccninetti, T.; Bach, D.; Raz, A.; and Shinitsky, N. 1978. Biochim. Biophys. Acta 512: 254.
Hayashi, M.; Okabe, J.; and Hozumi, M. 1979. Gann 70(2): 235–238.
Nidekazu, N.; Kazuhisa, T.; Miyano, K.; Yamane, T.; and Sato, J. 1982. Cancer Res. 42: 3858–3863.
Hirano, T.; Kuritani, T.; Kishimoto, T.; and Yamamura, Y. 1977. J. Immunol. 119: 1235–1241.
Hong, R.; Gatti, R.A.; and Good, R.A. 1968. Lancet 2: 288–389.
Honma, Y.; Takenaga, K.; Kasukabe, T.; and Hozumi, M. 1981. Biochem. Biophys. Res., Comm. 95: 507–512.
Housset, M.; Daniel, M.T.; and Degos, L. 1982. Brit. J. Haemat. 51: 125–129.
Hozumi, M. 1982. In Cancer Biology Reviews, eds. J.J. Marchalonis, M.G. Hanna, and I.J. Fiedler, vol. 3, p. 153. New York: Marcel Dekker.
Hozumi, M. 1983. Adv. Cancer Res. 38: 121.
Janassy, G.; Francis, G.E.; Capillano, D.; Goldstone, A.H.; and Greaves, M.F. 1978. Nature 276: 176–178.
Jetten, A.M. 1981. Ann. NY Acad. Sci. 119: 200–217.
Johnson, R.; et al. 1979. Int. J. Rad. Oncol. Biol. Phys. 5: 1605.
Kapoor, N.; Kirkpatrick, D.; Blaese, R.M.; Oleske, J.; Hilgartner, M.H.; Chaganti, R.S.K.; Good, R.A.; and O’Reilly, R.J. 1981. Blood 57: 692–696.
Keating, A.; Singer, J.W.; Killen, P.D.; Striker, G.E.; Salo, A.C.; Sanders, J.; Thomas, E.D.; Torning, D.; and Fialkow, P.J. 1982. Nature 298: 280–283.
Kessel, D. 1979. Mol. Pharmacol. 16: 306.
Koeffler, H.P., and Golde, D.W. 1978. Science 200: 1153.
Kraft, N.; Bradley, R.; Becker, G.; and Atkins, R.C. 1980. 4th International Congress on Immunology, vol. 11, pp. 1–14.
Kubanek, B.; Heit, W.; and Rich, I.N. 1981. Exp. Hematol. 9(Suppl.): 59.
Kurland, J.I.; Pelus, L.M.; Ralph, P.; Bockman, R.S.; and Moore, M.A.S. 1979. Proc. Natl. Acad. Sci. USA 76: 2326.
Lachman, L.B.; Hocker, M.P.; Blyden, G.T.; and Handschumacher, T. 1977. Cell Immunol. 34: 416–419.
Lambertsen, R.H., and Weiss, L. 1983. Am. J. Anat. 166: 369–392.
Lotem, J.; Lipton, J.H.; and Sachs, L. 1980. Intl. J. Cancer 25: 763–771.
Lu, L.; Broxmeyer, H.E.; Meyers, P.A.; and Moore, M.A.S. 1983. Blood 61: 250–256.
Maeda, M.; Horiuchi, M.; Numa, S.; and Ichikawa, Y. 1977. Gann 68: 435–447.
Maciag, T.; Cerumdolo, J.; Ilsley, S.; Kelley, P.R.; and Forand, R. 1979. Proc. Natl. Acad. Sci. USA 76: 5674–5678.
Messner, J.A.; Izaguirre, C.A.; and Jamal, N. 1981. Blood 58: 402.
Metcalf, D. 1979. Intl. J. Cancer 24(5): 616–623.
Metcalf, D. 1980. Intl. J. Cancer 25: 225–233.
Metcalf, D. 1982. J. Cell Physiol. 1(Suppl.): 175–183.
Metcalf, D., and Moore, M.A.S. 1970. J. Natl. Cancer Inst. 44: 801.
Metcalf, D.; Moore, M.A.S.; and Warner, N. 1969. Natl. Cancer Inst. 43: 983–1001.
Metcalf, D.; Parker, J.; Chester, H.M.; and Kincade, P.W. 1974. J. Cell Physiol. 84: 275.
Mittwoch, V. 1974. In Human Chromosome Methodology, ed. J.J. Yunis, pp. 73–93. New York: Academic Press.
Moore, M.A.S.; Broxmeyer, H.E.; Sheridan, A.P.C.; Jacobsen, N.; and Winchester, R.J. 1980. Blood 55: 682–690.
Moore, M.A.S., and Sheridan, A.P.C. 1979. Blood Cells 5: 297–311.
Moore, M.A.S., and Sheridan, A.P.C. 1982. In Maturation Factors in Cancer, ed. M.A.S. Moore, pp. 361–376. New York: Raven Press.
Moore, M.A.S.; Spitzer, G.; Williams, N.; Metcalf, D.; and Buckley, J. 1974. Blood 44: 1–11.
Nagata, K.; Ooguro, K.; Saito, M.; Kuboyama, M.; and Ogasa, K. 1977. Gann 68(6): 757–764.
Nicola, N.A.; Burgess, W.W.; and Metcalf, D. 1979. J. Biol. Chem. 254: 5290.
Nicola, N.A., and Metcalf, D. 1981. J. Cell. Physiol. 109(2): 253–264.
Olsson, I., and Olofsson, T. 1981. Exp. Cell Res. 131: 225–230.
Olsson, I.; Olofsson, T.; and Mauritzon, N. 1981. J. Nat. C.I. 67: 1225–1230.
O’Reilly, R.J.; Dupont, B.; Pahwah, S.; Gaines, E.; Smithwick, E.M.; Pawah, R.; Schwartz, S.; Hansen, J.A.; Siegal, F.P.; Sorell, M.; Svegaard, A.; Jersild, C.; Thompsen, M.; Platz, P.; L’Esperance, P.; and Good, R.A. 1977. N. Engl. J. Med. 297: 1131–1318.
Paige, C.J.; Kincade, P.W.; and Ralph, P. 1978. J. Immunol. 121: 641.
Pelus, L.M. 1982. J. Clin. Invest. 20: 568.
Pelus, L.M. 1983. Exp. Hematol. 10: 219–231.
Pelus, L.M.; Broxmeyer, H.E.; Clarkson, B.D.; and Moore, M.A.S. 1980a. Cancer Res. 40: 2512.
Pelus, L.M.; Broxmeyer, H.E.; Clarkson, B.D.; and Moore, M.A.S. 1980b. Cancer Res. 40: 2523.
Pelus L.M.; Broxmeyer, H.E.; DeSouse, M.; and Moore, M.A.S. 1981. J. Immunol. 126: 1016.
Pelus, L.M.; Gold, E.; Salenta, S.; and Coleman, M. 1983. Blood 62: 158–165.
Pelus, L.M.; Saletan, S.; Silver, R.; and Moore, M.A.S. 1982. Blood 59: 284.
Perussia, B.; Lebman, D.; Ip, S.H.; Rovera, G.; and Trinchieri, G. 1981. Blood 58(4): 836–843.
Pollack, M.S.; Mauer, D.; Callaway, C.; and Mattes, M.J. 1983. In Topics in Histocompatibility, eds. E.R. Heise and J.A. Hansen. Am. Assoc. Clin. Histocomp. 3: 37–50.
Pollack, M.S.; Mauer, D.; Levine, L.S.; New, M.I.; Pang, S.; Duchon, M.A.; Owens, R.P.; Merkatz, I.R.; Nitowsky, H.M.; Sachs, G.; and Dupont, B. 1979. Transplantation Proc. 11(4): 1726–1728.
Ralph, P.; Broxmeyer, H.E.; Moore, M.A.S.; and Nakoinz, I. 1978. Cancer Res. 38: 1414–1419.
Ralph, P.; Moore, M.A.S.; and Nilsson, K.J. 1976. Exp. Med. 143: 1528–1533.
Ralph, P.; Punjabi, C.J.; Welte, K.; Litcofsky, P.B.; Ho, M.K.; Moore, M.A.S.; and Springer, T.A. 1983. Blood 62: 1169–1175.
Ralph, P.; Williams, N.; Moore, M.A.S.; and Litcofsky, P.B. 1982. Cell Immunol. 71: 215–223.
Robinson, J.; Lieff, D.; Delia, D.; Edwards, P.A.W.; and Greaves, M. 1981. Nature 289: 68–71.
Rossi, G.B.; Migliaccio, A.R.; Migliaccio, G.; et al. 1980. Blood 56: 74–79.
Rovera, G.; O’Brien, T.G.; and Diamond, L. 1979. Science 204: 868.
Rubin, P.; Landman, S.; Mayer, E.; Keller, B.; and Ciccio, S. 1973. Cancer 32: 699.
Sachs, L. 1978. Nature 274: 535–539.
Salahuddin, S.Z.; Markham, P.D.; Ruscetti, F.W.; and Gallo, R.C. 1981. Blood 58(5): 931–937.
Schaeffer, W.I. 1979. In Vitro 15: 649–653.
Schwartz, E.; Brown, A.; Nierenburg, M.; Marsh, T.; and Sartorelli, A. 1982. Proc. Am. Assoc. Cancer Res. 23: 173.
Schwartz, E., and Sartorelli, A. 1982. Cancer Res. 42: 2651.
Springer, T.G.; Galfre, D.S.; Secher, S.; and Milstein, C. 1979. Eur. J. Immunol. 9: 301.
Takeda, K.; Minowada, J.; and Bloch, A. 1982. Cancer Res. 42: 5152.
Takenaga, K.; Honma, Y.; and Hozumi, M. 1981. Cancer Lett. 13: 1.
Trentin, J.J. 1976. In Stem Cells of Renewing Cell Populations, ed. D.G. Osmond, pp. 255–264. New York, London: Academic Press.
Trentin, J.J. 1980. In Regulation of Hematopoiesis, ed. A.S. Gordon, vol. 1, pp. 161–168. New York: Appleton-Century-Crofts.
Tsuchita, S.; Yamabe, M.; Yamaguchi, Y.; Kobayashi, Y.; Konno, T.; and Tada, K. 1980. Intl. J. Cancer 26: 171.
Uchida, I.A., and Lin, C.C. 1974. In Human Chromosome Methodology, ed. J.J. Yunis, pp. 47–58. New York: Academic Press.
Warner, N.; Moore, M.A.S.; and Metcalf, D. 1969. J. Natl. Cancer Inst. 43: 963.
Weiden, P.L.; Zuckerman, N.; Hansen, J.A.; Sale, G.E.; Remlinger, K.; Beck, T.M.; and Buckner, C.D. 1981. Blood 57: 328–332.
Weiss, B., and Sachs, L. 1978. Proc. Natl. Acad. Sci. USA 75(3): 1374–1378.
Welte, K.; Wang, C.Y.; Mertelsmann, R.; et al. 1982. J. Exp. Med. 156: 454.
Williams, N.; Eger, R.R.; Moore, M.A.S.; and Mendelsohn, N. 1978. Differentiation 11: 59.
Williams, N.; Jackson, H.; Ralph, P.; and Nakoinz, I. 1981. Blood 57: 157–163.
Wilson, F.D.; Greenberg, B.R.; Konrad, P.N.; Klein, A.K.; and Walling, P.A. 1978. Transplantation 25: 87–88.
Winchester, R.J.; Ross, G.D.; Jarowski, C.I.; Wang, C.Y.; Halper, J.; and Broxmeyer, H.E. 1977. Proc. Natl. Acad. Sci. USA 74: 4012–4016.
Yamamoto, Y.; Tomida, M.; Hozumi, M.; Ayusawa, D.; Seno, T.; and Tamura, G. 1981. Cancer Res. 41(6): 2534–2539.
Yung, Y.; Eger, G.; Tertian, G.; and Moore, M.A.S. 1981. J. Immunol. 127: 794.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Dr. S. Bernhard, Dahlem Konferenzen, Berlin
About this paper
Cite this paper
Moore, M.A.S. (1985). Regulatory Defects in Leukemia: In Vitro Analysis. In: Weissman, I.L. (eds) Leukemia. Life Sciences Research Reports, vol 30. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69722-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-69722-7_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69724-1
Online ISBN: 978-3-642-69722-7
eBook Packages: Springer Book Archive